Business Context and Reporting Period
This Form 8-K was filed by BioRestorative Therapies, Inc. on July 13, 2017. The report discloses the entry into a material definitive agreement involving a new loan from a director and principal stockholder.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, or margin data. The specific financial event reported is as follows:
- New Debt: $175,000 borrowed from John M. Desmarais.
- Interest Rate: 15% per annum.
- Maturity Date: December 1, 2017.
- Existing Debt: A separate $500,000 promissory note held by a trust for Mr. Desmarais' family, also maturing December 1, 2017.
- Collateral: Both notes are secured by a security interest in the Company's equipment and intellectual property.
Material Changes
The primary material change is the increase in short-term debt obligations and the encumbrance of company assets (equipment and intellectual property) to secure loans from a related party. The filing does not provide comparative period data for revenue or operating metrics.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or specific risk factors beyond the terms of the loan agreement. However, the loan agreement includes a prepayment trigger: if the Company receives net proceeds of $10,000,000 from a single equity or debt financing prior to maturity, Mr. Desmarais has the right to require prepayment of the note (subject to the consent of the new financing provider).
Investor Verification Checklist
- Verify the Company's current liquidity position and ability to repay $675,000 in related-party debt by December 1, 2017.
- Confirm the status of the Company's equipment and intellectual property to ensure they are not already pledged to other creditors.
- Monitor for any upcoming financing rounds that might trigger the $10,000,000 prepayment clause.
- Review the Company's most recent 10-K or 10-Q for baseline financial health, as this 8-K does not contain operational metrics.